{
  "authors": [
    {
      "author": "Mounia Bendari"
    },
    {
      "author": "Hanaa Bencharef"
    },
    {
      "author": "Nisrine Khoubila"
    },
    {
      "author": "Siham Cherkaoui"
    },
    {
      "author": "Mouna Lamchahab"
    },
    {
      "author": "Abdellah Madani"
    },
    {
      "author": "Mohamed Rachid"
    },
    {
      "author": "Meryem Qachouh"
    },
    {
      "author": "Bouchra Oukache"
    },
    {
      "author": "Asmaa Quessar"
    }
  ],
  "doi": "10.3889/oamjms.2018.396",
  "publication_date": "2019-01-05",
  "id": "EN112736",
  "url": "https://pubmed.ncbi.nlm.nih.gov/30607194",
  "source": "Open access Macedonian journal of medical sciences",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We report a case of 44-year-old women with secondary thymoma after chemotherapy treatment for T Acute Lymphoblastic leukaemia/lymphoma. Diagnosis of lymphoblastic/leukaemia lymphoma was made in 2015 by morphological and histological study. The patient underwent Moroccan protocol for acute lymphoblastic leukaemia (MARALL) from 2015 to 2017 and achieved complete remission. One year later, the patient developed an anterior mediastinal mass, relapse was suspected, but the surgical biopsy was performed and histological, the mass showed thymoma."
}